ATTOM Trial in Breast Cancer - Dr. Daniel Rea

Description: For more updates visit

Dr. Daniel Rea with updates on ECC 2013 Abstract #1860. Overall and subgroup findings of the aTTom trial: A randomised comparison of continuing adjuvant tamoxifen to 10 years compared to stopping after 5 years in 6953 women with ER positive or ER untested early breast cancer.
Shared By : oncologyeducation
Posted on : 10/07/13
Added : 6 years ago
Category : Breast Cancer